PROving its worth: how to develop a PRO strategy to distinguish your product with regulators and payers webinar (Europe)

September 12, 2018 | 2:00PM  -  3:00PM  (GMT+01:00) Central Europe Standard Time


Patient reported outcomes (PRO) are gaining in importance in therapy areas that have been dominated historically by biomarkers or event-based endpoints. Change in requirements for PRO evidence and a rising bar for its quality are being driven by regulators but payers are also increasingly demanding high-quality patient-relevant outcomes. To meet new requirements and to differentiate its products, Pharma must integrate the patient experience strategy into its development programmes. This webinar features case studies and helps understand the evolving PRO landscape, how they are assessed by payers and regulators and how you can be successful in this challenging environment and develop a strategy that meets these requirements.